Roche (RHHBY) and Novartis (NVS) tout their U.S. investments as President Donald Trump imposes new 100% pharma tariffs. Read ...
Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast ...
Trump’s threat of a 100% tariff on imported branded or patented drugs sounds dramatic, yet, pharma stocks were mostly in the ...
President Trump said he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, ...
Eli Lilly and Company (NYSE: LLY) is one of the 10 Best AI Stocks to Buy According to Goldman Sachs. On September 18, Wells ...
Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. The secondary endpoints ...
Even though Eli Lilly and Company (NYSE:LLY)’s shares have lost 6.9% year-to-date, Cramer continues to be a believer in the ...
Eli Lilly plans to build a $6.5 billion factory in Houston, with construction expected to be completed by 2030.
Pharmaceutical Technology on MSN
FDA approves Lilly’s Inluriyo to treat advanced breast cancer
Lilly has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant) to treat advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback